Real-time enrollment status for this cholangiocarcinoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 2:01 PM UTC
| NCT Number | NCT05948475 |
| Recruiting Status | Recruiting |
| Condition | Cholangiocarcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 200 participants |
| Active Locations | 19 sites in the US |
| Sponsor | TransThera Sciences (Nanjing), Inc. |
| Last Updated on CT.gov | June 24, 2024 (Jun 24, 2024) |
As of March 2, 2026: Clinical trial NCT05948475 is currently recruiting participants. This clinical trial study for cholangiocarcinoma is actively seeking new participants at 19 locations across the United States. The study is sponsored by TransThera Sciences (Nanjing), Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05948475 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05948475 was last updated Jun 24, 2024 (June 24, 2024). HelloStudys verifies this status automatically.